Skip to main content

Definition

Aromatase is a cytochrome P450, hemoprotein-containing enzyme, located in the endoplasmic reticulum, which catalyzes the rate-limiting step in the conversion of androgens (androstenedione and testosterone), to estrogens (estrone and estradiol). Agents that inhibit aromatase (aromatase inhibitors) are widely used to prevent the development and progression of estrogen dependent breast cancers.

Basic Characteristics

Estrogen biosynthesis is mediated by the aromatase enzyme, which is a product of the CYP19 gene. The aromatase enzyme is a complex that consists of cyctochrome P450 hemoprotein and a flavoprotein, NADPH-cytochrome P450 reductase. This complex is responsible for catalyzing the conversion of steroidal C-19 androgens (androstenedione and testosterone) to C-18 estrogens (estrone and estradiol), which is the rate-limiting final step in the synthesis of estrogens (Fig. 1). This enzymatic reaction is comprised of three steps each of which requires 1M equiv. of NADPH and...

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 849.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 999.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Simpson ER, Clyne C, Rubin G et al (2002) Aromatase – A Brief Overview. Annu Rev Physiol 54:93–127

    Article  Google Scholar 

  2. Dowsett M (1996) Biological background to aromatase inhibition. Breast 5:196–201

    Article  Google Scholar 

  3. Dixon MJ (2006) Aromatase inhibitors in early beast cancer therapy: a variety of treatment strategies. Expert Opin 7:(18)2465–2479

    Article  CAS  Google Scholar 

  4. Buzdar AU (2005–2006) Aromatase inhibitors: changing the face of endocrine therapy for breast cancer. Breast dis 24: 107–117

    CAS  Google Scholar 

  5. Pandya N, Morris GJ (2006) Toxicity of Aromatase Inhibitors. Semin Oncol 33:688–695

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer-Verlag Berlin Heidelberg New York

About this entry

Cite this entry

Shaheenah, D., Fellow, S.G.K., Buzdar, A.U. (2008). Aromatase. In: Offermanns, S., Rosenthal, W. (eds) Encyclopedia of Molecular Pharmacology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-38918-7_236

Download citation

Publish with us

Policies and ethics